Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03210883 · ClinicalTrials.gov registry record
Global Electrical Heterogeneity and Clinical Outcomes
A clinical trial of Heart Failure and Implantable Defibrillator User, sponsored by Larisa Tereshchenko.
- Completed
- Registry status
- 3,471
- Enrollment target
- 6
- Study locations
NCT03210883 is a study of Heart Failure and Implantable Defibrillator User that has completed, run by Larisa Tereshchenko. The registered enrollment target is 3,471 participants, above the 2,040-participant average among 397 other Heart Failure trials with a reported enrollment target (70% higher). The trial reports 6 study locations across 4 states.
The verdict
NCT03210883, a study of Heart Failure and Implantable Defibrillator User, has completed, sponsored by Larisa Tereshchenko.
- COMPLETED
- Registry status
- 3,471 participants
- Enrollment target
- 6
- Study locations
Study Summary
This retrospective multicenter cohort will validate an independent association of electrocardiographic (ECG) global electrical heterogeneity (GEH) measures with sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD, and will validate and re-calibrate GEH ECG risk score for prediction of sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD.
Conditions Studied
Study Locations (6)
California
- Cedars-Sinai Medical Center - Los Angeles
- Stanford University - Stanford
Oregon
- Oregon Health and Science University - Portland
- Veteran Administration Portland Healthcare System - Portland
Colorado
- University of Colorado - Aurora
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,471 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2021-07-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03210883
The ClinicalTrials.gov registry entry for NCT03210883 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,471 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,040-participant average among 397 other Heart Failure trials with a reported enrollment target (70% higher). The listed sponsor is Larisa Tereshchenko, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT03210883 reports 6 study locations spanning 4 distinct geographic areas - top geographies include California, Oregon, Colorado.
Frequently Asked Questions
What is clinical trial NCT03210883 about?
NCT03210883 is a clinical study titled "Global Electrical Heterogeneity and Clinical Outcomes". This retrospective multicenter cohort will validate an independent association of electrocardiographic (ECG) global electrical heterogeneity (GEH) measures with sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD, and wi...
What is the current status of trial NCT03210883?
This trial is currently completed. The enrollment target is 3,471 participants. The study started on 2017-07-01. Estimated completion is 2021-07-05.
What conditions does trial NCT03210883 study?
This clinical trial studies the following conditions: Heart Failure, Implantable Defibrillator User, Ventricular Arrythmia.
Who is sponsoring clinical trial NCT03210883?
This trial is sponsored by Larisa Tereshchenko, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03210883 being conducted?
This trial has 6 study locations across California, Colorado, Massachusetts, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.